Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06310187 · ClinicalTrials.gov registry record · NA

Little Cigar Oxidants

A NA study, sponsored by Milton S. Hershey Medical Center.

Recruiting
Registry status
NA
Development phase
50
Enrollment target

NCT06310187: Recruiting NA study, sponsored by Milton S. Hershey Medical Center.

NCT06310187 is a NA study that is actively recruiting participants, run by Milton S. Hershey Medical Center. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06310187, a NA study, is actively recruiting participants, sponsored by Milton S. Hershey Medical Center.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

Determine the effects of little cigars on human exposure to tobacco smoke oxidants. In a balanced randomized cross-over study design in cigarette smokers, subjects will be assigned to 3 exposure groups. These include a high oxidant little cigar exposure condition, a low oxidant little cigar exposure condition, and their usual cigarette. Biological samples will be collected before and after product usage.

Interventions

  • OTHER High Oxidant Little Cigar
  • OTHER Low Oxidant Little Cigar
  • OTHER Usual Cigarette

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-03-25
Est. Completion 2029-08
Phase NA
Milton S. Hershey Medical Center

396 total trials

What NCT06310187 shows while recruiting

NCT06310187 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 3 interventions - of which High Oxidant Little Cigar is the first listed.

NCT06310187 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06310187 about?

NCT06310187 is a clinical study titled "Little Cigar Oxidants". Determine the effects of little cigars on human exposure to tobacco smoke oxidants. In a balanced randomized cross-over study design in cigarette smokers, subjects will be assigned to 3 exposure groups. These include a high oxidant little cigar exposure condition, a low oxidant little cigar exposure...

What is the current status of trial NCT06310187?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-03-25. Estimated completion is 2029-08.

What interventions are being tested in trial NCT06310187?

The interventions under investigation include: High Oxidant Little Cigar (OTHER), Low Oxidant Little Cigar (OTHER), Usual Cigarette (OTHER).

Who is sponsoring clinical trial NCT06310187?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06310187's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06310187, the US trial registry maintained by the National Library of Medicine. NCT06310187 (small enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.